Validity and Reliability of the Exergame Enjoyment Questionnaire (EEQ) in Turkish
25 avril 2026 mis à jour par: Gulfidan Tokgoz, Istanbul University - Cerrahpasa
Validity and Reliability of the Exergame Enjoyment Questionnaire (EEQ) in a Geriatric Population in Turkish
The aim of this research is to adapt the Exergame Enjoyment Questionnaire (EEQ) into Turkish and to evaluate its suitability for the Turkish elderly population through validity and reliability analyses.
After the cultural adaptation process is completed, the construct validity of the scale will be evaluated using exploratory and confirmatory factor analyses; its reliability will be assessed through internal consistency coefficients (Cronbach's alpha) and test-retest reliability over time (ICC).
Accordingly, the study aims to provide a valid and reliable assessment tool for clinicians and researchers who wish to evaluate individual experiences in exergaming-based interventions.
Aperçu de l'étude
Statut
Pas encore de recrutement
Les conditions
Intervention / Traitement
Description détaillée
While regular exercise plays a critical role in maintaining the physical and cognitive health of the growing elderly population, barriers such as lack of motivation, physical limitations, and boredom restrict participation in exercise among the elderly.
Multimodal "exergaming" applications, which combine exercise and gamification dynamics, offer an innovative and enjoyable alternative that enhances the motivation, balance, cognitive skills, and coordination of older individuals.
The long-term success of exergaming interventions and the sustainability of participation should be evaluated not only by physical outcomes but also by psychosocial motivational parameters such as enjoyment, flow, and sense of control derived from the game.
The Exergame Experience Questionnaire (EEQ) stands out in the literature for measuring this experience.
However, the EEQ scale, in its current form, is only valid within the English-speaking cultural context.
Despite the increasing prevalence of exergaming applications in Türkiye, the lack of a psychometrically robust and culturally adapted measurement tool capable of evaluating this experience in a multidimensional way hinders the individualization of interventions and the measurement of their effectiveness.
This study aims to address this deficiency.
Type d'étude
Observationnel
Inscription (Estimé)
46
Contacts et emplacements
Cette section fournit les coordonnées de ceux qui mènent l'étude et des informations sur le lieu où cette étude est menée.
Coordonnées de l'étude
- Nom: GULFİDAN TOKGÖZ, Lecturer, PhD (c)
- Numéro de téléphone: 0552 022 76 32
- E-mail: gulfidan.tokgoz@gmail.com
Lieux d'étude
-
-
-
Balıkesir, Turquie (Türkiye)
- Balıkesir Üniversitesi
-
Contact:
- GULFİDAN TOKGÖZ, Lecturer, PhD (c)
- Numéro de téléphone: 0552 022 76 32
- E-mail: gulfidan.tokgoz@gmail.com
-
Sous-enquêteur:
- Bilal Katipoğlu, Assoc. Prof. Dr.
-
Sous-enquêteur:
- Nilay ARMAN, Assoc. Prof. Dr.
-
-
Critères de participation
Les chercheurs recherchent des personnes qui correspondent à une certaine description, appelée critères d'éligibilité. Certains exemples de ces critères sont l'état de santé général d'une personne ou des traitements antérieurs.
Critère d'éligibilité
Âges éligibles pour étudier
- Adulte plus âgé
Accepte les volontaires sains
Oui
Méthode d'échantillonnage
Échantillon non probabiliste
Population étudiée
The study population consists of individuals aged 65 and over residing in the city center of Balıkesir.
Accordingly, the sample group will be comprised of volunteer elderly individuals who meet the specified inclusion criteria, have a cognitive capacity suitable for data collection, and have experience with the exergaming applications included in the study protocol.
La description
Inclusion Criteria:
- Being 65 years of age or older
- Having participated in an exergaming application at least once before
- Not having a physical, sensory or cognitive disability that would prevent participation in the exergaming application
- Agreeing to participate voluntarily and providing informed consent
Exclusion Criteria:
- Individuals with active neurological, vestibular, or psychiatric disorders
- Individuals diagnosed with moderate or severe cognitive impairment (MMSE < 24 and/or MoCA < 21)
- Individuals with severe hearing or vision loss
- Individuals who are physically unable to participate in exergaming due to cardiopulmonary or orthopedic reasons
- Individuals with no prior exergaming experience
- Individuals who experience significant communication difficulties
- Participants who do not sign the voluntary consent form
Plan d'étude
Cette section fournit des détails sur le plan d'étude, y compris la façon dont l'étude est conçue et ce que l'étude mesure.
Comment l'étude est-elle conçue ?
Détails de conception
Cohortes et interventions
Groupe / Cohorte |
Intervention / Traitement |
|---|---|
|
Geriartric Indivıduals
The study population consists of individuals aged 65 and over residing in the city center of Balıkesir.
|
The adaptation process of the Exergame Enjoyment Questionnaire (EEQ) into Turkish will be carried out following the forward-backward translation method proposed by Beaton et al. (2000), which has international validity.
In this context, the scale will first be translated from English to Turkish by two independent translators, one a healthcare specialist and the other a professional language expert.
These two translations will then be compared to create a common preliminary text; subsequently, this text will be translated back into English by two independent translators whose native language is English and who are familiar with the conceptual content, and any loss of meaning will be evaluated.
The resulting Turkish draft will be reviewed by an expert panel for cultural appropriateness, linguistic clarity, and conceptual equivalent; necessary adjustments will be made.
Finally, the scale will be piloted on 10 elderly individuals selected from the target population, and feedback on the com
|
Que mesure l'étude ?
Principaux critères de jugement
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Exergame Enjoyment Questionnaire (EEQ)
Délai: 2 weeks
|
The Exergame Enjoyment Questionnaire (EEQ) is a self-report, multidimensional measurement tool developed to assess the level of enjoyment individuals experience while participating in exercise-based digital games (Fitzgerald et al.). The scale allows for a comprehensive assessment of both the structural characteristics of the digital game and the experience related to physical activity (Fitzgerald et al.). The original form of the EEQ consists of a total of 20 items, adapted from scales such as the Game Engagement Questionnaire (GEQ), Immersive Experience Questionnaire (IEQ), and Physical Activity Enjoyment Scale (PACES), which have previously proven their validity and reliability (Fitzgerald et al.). Each item is answered using a 5-point Likert scale ranging from 1 (Strongly Disagree) to 5 (Strongly Agree). The scale items are structured in four sub-dimensions: Immersion, Intrinsically Rewarding Activity, User Control, and Exercise Experience. O |
2 weeks
|
Mesures de résultats secondaires
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Physical Activity Enjoyment Scale (PAES)
Délai: 1 weeks
|
The Physical Activity Enjoyment Scale (PAES) is a self-report psychometric scale developed to assess the level of enjoyment individuals experience while participating in physical activity (Mullen et al., 2011; Özkurt et al., 2022).
The Turkish adapted version of the scale was introduced to the Turkish population by Özkurt et al. (2022) after completing the cultural adaptation process and validity and reliability analyses.
PAES has a single-factor structure consisting of 8 items.
Each item is answered with a 7-point Likert scale ranging from 1 (Strongly Disagree) to 7 (Strongly Agree) (Özkurt et al., 2022).
High scores obtained from the scale indicate that the individual experiences a high level of enjoyment during physical activity.
The scale's internal consistency coefficient (Cronbach's alpha = 0.96) and composite reliability value (CR = 0.95) were found to be high, indicating that the scale has strong psychometric properties (Özkurt et al.,
|
1 weeks
|
Collaborateurs et enquêteurs
C'est ici que vous trouverez les personnes et les organisations impliquées dans cette étude.
Parrainer
Publications et liens utiles
La personne responsable de la saisie des informations sur l'étude fournit volontairement ces publications. Il peut s'agir de tout ce qui concerne l'étude.
Publications générales
- Özkurt, B., Küçükibiş, H. F., & Eskiler, E. (2022). Fiziksel Aktivitelerden Keyif Alma Ölçeği (FAKÖ): Türk Kültürüne Uyarlama, Geçerlik ve Güvenirlik Çalışması. Anemon Muş Alparslan Üniversitesi Sosyal Bilimler Dergisi, 10(1), 21-37. https://doi.org/10.18506/anemon.976300
- Fitzgerald, A., Huang, S., Sposato, K., Wang, D., Claypool, M., & Agu, E. (2020). The Exergame Enjoyment Questionnaire (EEQ): An instrument for measuring exergame enjoyment. Proceedings of the Hawaii International Conference on System Sciences (HICSS).
Dates d'enregistrement des études
Ces dates suivent la progression des dossiers d'étude et des soumissions de résultats sommaires à ClinicalTrials.gov. Les dossiers d'étude et les résultats rapportés sont examinés par la Bibliothèque nationale de médecine (NLM) pour s'assurer qu'ils répondent à des normes de contrôle de qualité spécifiques avant d'être publiés sur le site Web public.
Dates principales de l'étude
Début de l'étude (Estimé)
30 avril 2026
Achèvement primaire (Estimé)
15 mai 2026
Achèvement de l'étude (Estimé)
30 septembre 2026
Dates d'inscription aux études
Première soumission
25 avril 2026
Première soumission répondant aux critères de contrôle qualité
25 avril 2026
Première publication (Réel)
1 mai 2026
Mises à jour des dossiers d'étude
Dernière mise à jour publiée (Réel)
1 mai 2026
Dernière mise à jour soumise répondant aux critères de contrôle qualité
25 avril 2026
Dernière vérification
1 avril 2026
Plus d'information
Termes liés à cette étude
Mots clés
Termes MeSH pertinents supplémentaires
Autres numéros d'identification d'étude
- 2026/45
Plan pour les données individuelles des participants (IPD)
Prévoyez-vous de partager les données individuelles des participants (DPI) ?
NON
Informations sur les médicaments et les dispositifs, documents d'étude
Étudie un produit pharmaceutique réglementé par la FDA américaine
Non
Étudie un produit d'appareil réglementé par la FDA américaine
Non
Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .